Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
C.20ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.221.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.224ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.618ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.458ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.22ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AG.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.258.16ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
W.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.264.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.75.3 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.35ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CY.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FR.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBJ.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CP.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GJ.1.2.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CK.1.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.56.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.21ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.13.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.37ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CK.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CM.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBC.1.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.11.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDLENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.29.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.29.2 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BC.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.10.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.3.13ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.3.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.10.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.56ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.29ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.338ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BG.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.20.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XVENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.38.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4.1.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.80ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.134ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CZ.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used